Nchi: Ugiriki
Lugha: Kiingereza
Chanzo: HMA (Heads of Medicines Agencies)
bismuth subnitrate 2600 mg
Norbrook Laboratories Limited
QG52X
Intramammary suspension
VARIOUS PRODUCTS FOR TEATS AND UDDER
Cattle Food
2013-06-26
Issued: August 2013 AN. 00454/2012 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Noroseal 2.6g Intramammary Suspension for Cattle (AT, CZ, DK, FI, DE, EL, HU, IE, PL, RO, UK) Intraseal 2.6g Intramammary Suspension for Cattle (BE, BG, CY, EE, ES, IT, LT, LU, LV, MT, NL, NO, PT, SE, SI, SK) Noroseal Intramammary Suspension for Cattle (FR) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 4g Intramammary syringe contains: Active substance: Bismuth subnitrate, heavy 2.6g For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Intramammary suspension Light brown suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (dairy cows) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Prevention of ascending intramammary infections throughout the dry period. In cows considered likely to be free of sub-clinical mastitis, the product may be suitable for use on its own in dry cow management for mastitis control. Selection of cows for treatment with the product should be based on veterinary clinical judgement. Selection criteria may be based on the mastitis and cell count history of individual cows, or recognised tests for the detection of sub-clinical mastitis or bacteriological sampling. 4.3 CONTRAINDICATIONS Do not use the product alone in cows with clinical or sub-clinical mastitis at drying off period. See section 4.5 Do not use during lactation. Issued: Soma hati kamili